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Abstract
Cyanobacteria are widely recognized as a valuable source of bioactive metabolites. The majority of such compounds have
been isolated from so-called complex cyanobacteria, such as filamentous or colonial forms, which usually display a larger
number of biosynthetic gene clusters in their genomes, when compared to free-living unicellular forms. Nevertheless,
picocyanobacteria are also known to have potential to produce bioactive natural products. Here, we report the isolation of
hierridin B from the marine picocyanobacterium Cyanobium sp. LEGE 06113. This compound had previously been isolated
from the filamentous epiphytic cyanobacterium Phormidium ectocarpi SAG 60.90, and had been shown to possess
antiplasmodial activity. A phylogenetic analysis of the 16S rRNA gene from both strains confirmed that these cyanobacteria
derive from different evolutionary lineages. We further investigated the biological activity of hierridin B, and tested its
cytotoxicity towards a panel of human cancer cell lines; it showed selective cytotoxicity towards HT-29 colon
adenocarcinoma cells.
Citation: Lea˜o PN, Costa M, Ramos V, Pereira AR, Fernandes VC, et al. (2013) Antitumor Activity of Hierridin B, a Cyanobacterial Secondary Metabolite Found in
both Filamentous and Unicellular Marine Strains. PLoS ONE 8(7): e69562. doi:10.1371/journal.pone.0069562
Editor: Brett Neilan, University of New South Wales, Australia
Received February 22, 2013; Accepted June 10, 2013; Published July 29, 2013
Copyright:  2013 Lea˜o et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: PNL, MC and VR acknowledge funding from FCT – Foundation for Science and Technology (SFRH/BPD/70233/2010, BTI/PTDC/MAR/102638/2008/2010-
025 and SFRH/BD/80153/2011, respectively). This research was partially supported by the European Regional Development Fund (ERDF) through the COMPETE -
Operational Competitiveness Programme and national funds through FCT, under the projects PEst-C/MAR/LA0015/2011, PTDC/MAR/102258/2008 and PTDC/
MAR/102638/2008. WHG acknowledges funding from the National Institutes of Health CA100851. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pleao@ciimar.up.pt
. These authors contributed equally to this work.
Introduction
Marine cyanobacteria have been shown to produce a diverse
array of biologically significant natural products with activity in
models for anticancer, neuromodulatory and anti-inflammatory
drug discovery, and other areas [1]. Benthic, filamentous forms,
in particular members of the classical (botanical) orders
Oscillatoriales and Nostocales, have been the major sources of
secondary metabolites reported from marine cyanobacteria [2].
This is in part explained by the fact that filamentous and
colonial cyanobacteria appear to have larger genomes and thus
can better accommodate sizable polyketide and non-ribosomal
peptide pathways than picocyanobacteria [3,4]. These classes of
biosynthetic products make up the majority of secondary
metabolites isolated from cyanobacteria thus far [2], although
a previously unrecognized capacity to produce ribosomally-
encoded modified peptides has recently been described [5,6].
Another consideration is that some filamentous and colonial
cyanobacteria grow to relatively high densities in coastal
ecosystems, such as in mats or macroscopic tufts, thus yielding
enough biomass for chemical investigations from environmental
samples.
Conversely, unicellular cyanobacteria usually need to be
cultured in order to produce sufficient biomass for chemical and
biological studies. The lack of ‘‘chemistry-ready’’ environmental
samples and the difficulty to bring certain strains into laboratory
culture may have skewed our perception of the richness of such
smaller genome size cyanobacteria in terms of secondary
metabolite production. As an example, the marine picocyanobac-
terium Prochlorococcus, which is widespread in open ocean waters,
produces a complex set of polycyclic lantipeptides [6]. The
unicellular, not-yet-cultured symbiotic cyanobacterium Prochloron
didemni is also known to produce a diverse array of secondary
metabolites, including cyclic peptides and unusual fatty acids [7].
It should be noted that both of these examples report metabolites
of a ribosomal origin, which may be a trend in picocyanobacteria
as these more compact biosynthetic gene clusters may be better
accommodated in small genomes.
The bioactive potential of picoplanktonic marine cyanobacteria
has also been investigated by our group, with a focus on several
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Synechococcus and Synechocystis strains isolated from the Portuguese
coast [8]. A recent survey of cyanobacterial genomes [4] indicated
the presence of biosynthetic gene clusters, mainly of the polyketide
synthetase (PKS) and bacteriocin variety, among picocyanobac-
teria genera Cyanobium, Synechococcus and Prochlorococcus.
Here, we report the NMR-based isolation of hierridin B (1,
Fig. 1) from the picocyanobacterium Cyanobium sp. LEGE 06113
which had been isolated from the Atlantic coast of Portugal. The
structure of 1 was confirmed by NMR and MS analyses. To our
knowledge, this is the first report of a secondary metabolite from
this cyanobacterial genus. Compound 1 had previously been
isolated from the marine filamentous cyanobacterium Phormidium
ectocarpi strain SAG 60.90 and showed antiplasmodial activity [9].
We show that both cyanobacterial strains possess polyketide
synthase (PKS) biosynthetic machinery, which is predicted to be
involved in the biosynthesis of hierridin B. To further investigate
the biological properties of this metabolite, we treated a panel of
eight human cell lines to this compound. Interestingly, when tested
up to a maximum concentration of 30 mg mL21 (82.3 mM),
hierridin B was only active against the colorectal adenocarcinoma
cell line HT-29.
Results
Isolation and identification of hierridin B
A crude lipophilic extract from Cyanobium sp. LEGE 06113
was fractionated using vacuum-liquid chromatography (VLC).
The 1H NMR spectrum (500 MHz, CDCl3) of one of the most
non-polar fractions contained two sharp singlets at d3.85 and
d3.76, suggestive of aromatic methoxy groups, which led us to
further investigate this fraction and ultimately obtain compound
1 after purification by reversed-phase (RP) HPLC. Identification
of the compound was initially based on comparison of the 1H
NMR data with literature values for hierridin B and for one
extended chain analogue, which had been previously reported
[9] (Fig. S1). The length of the aliphatic chain of the isolated
compound could not, however, be rigorously derived from the
integration of the 1H NMR signals corresponding to the
methylene envelope at d1.30-1.23. Consequently, GC-MS data
of the compound were acquired (no ionization was observed
under our standard LC-ESI-MS conditions) and the identity of
the purified metabolite was confirmed as hierridin B, due to the
characteristic ions observed at m/z 364 [C23H40O3], m/z 168
[C9H12O3] (aromatic moiety following benzylic fragmentation
and McLafferty rearrangement) and m/z 167 (benzylic moiety)
(Fig. 2). Papendorf et al. [9] had used mass spectrometry data to
aid in the structural characterization of metabolite 1 following
its partial purification from P. ectocarpi SAG 60.90. In the
previous work with P. ectocarpi, the hierridins were obtained as a
1:1 mixture of 1 (pentadecyl-containing) and its heptadecyl
analogue, both of which yielded the same fragment mass at m/z
168, but for which a molecular ion was observed at m/z 392 for
the larger compound. We saw no evidence for the heptadecyl-
containing metabolite in our materials from Cyanobium sp. LEGE
06113, nor could we find evidence for the presence of any other
structurally related compound.
Morphological and phylogenetic analyses
Cells from Cyanobium sp. LEGE 06113 (Fig. 3A) are pale blue-
green, spherical to shortly rod-shaped, with a diameter of
0.960.1 mm (n = 20). Based on these morphological character-
istics, the cyanobacterium was identified as Cyanobium sp.,
according to Komare´k and Anagnostidis [10]. This identifica-
tion is also in accordance with the criteria of the Bergey’s
Manual of Systematic Bacteriology [11]. Since hierridin B had
been previously reported from the filamentous cyanobacterial
strain P. ectocarpi SAG 60.90 (see morphology comparison in
Fig. 3), we performed a 16S rRNA gene phylogenetic analysis
to clarify the evolutionary relatedness between the two
hierridin B producing cyanobacterial strains. From the
phylogenetic tree (Fig. 4), it is clear that Cyanobium sp. LEGE
06113 is located in the same clade as other picocyanobacteria.
This strain forms a sub-clade with the reference strain
Cyanobium sp. PCC 7001; interestingly, the PCC 7001 sample
was also isolated primarily from intertidal sediments [11]. This
analysis also identifies that Phormidium ectocarpi SAG 60.90 is
very closely related to other marine, phycoerythrin-rich
filamentous cyanobacteria, including the reference strain
Leptolyngbya sp. PCC 7375 (cluster 4, [11,12]; formerly assigned
to P. ectocarpi [13]). However, it is also clear that all of the
above strains are encompassed within a wider clade that also
includes the picocyanobacterium Synechococcus sp. PCC 7335. It
should be noted that the clustering of the two clades that
comprise each of the two hierridin B producers has no
phylogenetic strength, because it lacks statistical support (ML
bootstrap value of 44%) (Fig. 4).
Presence of PKS genes
We have employed a PCR-based approach to detect the
presence of PKS-related genes, by using degenerate primers
targeting ketosynthase (KS) domains [14]. This allowed for the
detection of one type I PKS gene fragment in Cyanobium sp. LEGE
06113 and two type I PKS gene fragments in P. ectocarpi SAG
60.90. The amino acid sequence identity between the two P.
ectocarpi PKS genes was 54%. The identities between the Cyanobium
sp. and each of the two P. ectocarpi PKS gene sequences, also at the
amino acid level, were of 45% and 47%, respectively. From
NaPDoS phylogenetic analysis [15], the sequences from P. ectocarpi
were found to bear homology and cluster with the KS domains
from trans-AT type I PKSs VirF, CurF, JamJ and LnmJ
(virginiamycin, curacin A, jamaicamides A and B, and leinamycin
biosynthetic clusters, respectively). The sequence from Cyanobium
sp. was shown to cluster with the starter KS domains from the
biosynthetic gene clusters of curacin A (CurA) and jamaicamides A
and B (JamE).
Biological activity
While antiplasmodial activity was reported for 1 as a 1:1
mixture with its two-carbon longer analogue [9], any information
regarding its cytotoxicity towards human cells was not available.
Therefore, we tested pure hierridin B to a panel of eight human
cell lines (Table 1). When evaluated up to a maximum
concentration of 30 mg mL21 (82.3 mM), cytotoxicity was ob-
served only to colon adenocarcinoma HT-29 cells (Table 1). A
concentration-response assay (up to 100 mg mL21) revealed its
IC50 as 100.2 mM in this cell line (Fig. S2).
Figure 1. Structure of hierridin B (1).
doi:10.1371/journal.pone.0069562.g001
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Discussion
Biogenesis
Feeding studies coupled with intermediate analysis by Horper
and Marner [16,17] on miconidin and some of its derivatives
(including miconidin methyl ether 2 (Fig. 5), a shorter chain
analogue of 1) provided evidence for the polyketide nature of these
metabolites, isolated from the plant Primula obconica [17]. The
biosynthesis of 2 is thus proposed [16] to involve a triketoacid
(2,4,6-trioxoundecanoic acid), which is cyclized, dehydrated and
decarboxylated to yield 5-pentylbenzene-1,3-diol. This pathway
intermediate leads to a variety of end products, including 2,
following methylation and oxidation. Another end-product of this
putative pathway is the benzoquinone primin (3, Fig. 5), produced
by the same plant [17]. Analogous long-chain quinones have been
reported from the plant kingdom; for example, 2-methoxy-6-
pentadecyl-1,4-benzoquinone (4, Fig. 5) from Iris pseudacorus seeds
[18] features a pentadecyl chain, as seen in 1. Belamcandol A (5,
Figure 2. GC-MS analysis of purified 1. Top panel – total ion chromatogram (TIC). Bottom panel – mass spectrum of the main chromatographic
peak (RT = 28.1 min), with the diagnostic ions for hierridin B at m/z 364 and 168 clearly seen.
doi:10.1371/journal.pone.0069562.g002
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Fig. 5), found in the seeds of Belamcanda chinensis [19], is an
unsaturated analogue of 1. All of these long-chained metabolites
generally can be explained by the biogenetic model put forward by
Horper and Marner [16] for 2 and 3. A similar biosynthetic origin
is thus envisioned for 4, 5 and 1. In the present study, however, no
evidence was found for the presence of any other end products or
intermediates that could originate from an analogous biosynthetic
route to 1. Still, taking into account the small amount of
compound 1 that we were able to purify, such metabolites may
not have been detected during our isolation procedures. The alkyl
side chain in 2 and 3 has been proposed [16] to originate from
acetyl-CoA which is polymerized by a PKS assembly line, rather
than hexanoic acid being used as a starter unit. The recently
reported biosynthetic route to the cylindrocyclophanes in the
filamentous heterocystous cyanobacterium Cylindrospermum licheni-
forme [20] involves an alkylresorcinol intermediate (6) that is
structurally related to hierridin B. In this case, decanoic acid is
used as the starter unit. The concerted action of two type I PKSs
leads to a diketo intermediate, which is then cyclized by a type III
PKS to 6 [20]. In the case of 1, one can only speculate on whether
palmitic acid primes this biosynthetic pathway, or whether a PKS
is involved in the constructing the entire carbon framework. A
polyketide origin for 1 is further supported by the fact that both
hierridin B-producing cyanobacteria bear type I PKS machinery.
Nevertheless, we were unable to find highly homologous KS
domains shared by the two organisms, which would strengthen
this hypothesis. It is unlikely that the PKS gene found in Cyanobium
sp. LEGE 06113 is involved in the same biosynthetic transforma-
tion as any of the PKS genes found in the P. ectocarpi strain.
However, it is possible that the three recovered KS domains
Figure 3. Microphotographs of the two cyanobacterial strains
known to produce 1. A – Cyanobium sp. LEGE 06133; B – Phormidium
ectocarpi SAG 60.90. Scale bar = 20 mm.
doi:10.1371/journal.pone.0069562.g003
Figure 4. Maximum likelihood tree of 16S rRNA gene sequences from selected cyanobacteria and from the two strains known to
produce metabolite 1. The nodal support values indicated near internal branches were determined by ML and BI methods, respectively; bootstrap
values (for ML) below 70% and posterior probability values (for BI) below 0.90 were omitted. Thick branch lines indicate clades (or sub-clades) that are
supported by simultaneous $85% bootstrap values and$0.95 bayesian posterior probabilities. The tree was rooted using Chloroflexus aurantiacus J-
10-fl (D38365) as the outgroup, which was removed for clarity. Asterisks indicate concatenated sequences.
doi:10.1371/journal.pone.0069562.g004
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correspond to different portions of the putative hierridin B
pathway. The fact that all of these domains show highest
homology to KS domains involved in curacin A and jamaicamides
biosynthesis is consistent with such a scenario.
Phylogenetic inferences
Our phylogenetic analysis, motivated by the aim of under-
standing how related the two hierridin B producer strains are to
one another, revealed that Cyanobium sp. LEGE 06113 and
Phormidium ectocarpi SAG 60.90 are clearly located in two distinct
clades. Although these two clades emerged from the analysis as
being more closely related to one another than with the other
cyanobacterial lineages (Fig. 4), a common evolutionary lineage
could not be established. Thus, it is improbable that the
biosynthesis of this compound is deeply entrenched in the two
lineages since their divergence. In fact, the findings of Shih et al.
[4], point out that the genomes of some reference strains included
in our phylogenetic study do not contain polyketide gene clusters,
such as Synechococcus sp. PCC 7335 and the filamentous cyano-
bacterium Prochlorothrix hollandica PCC 9006 (axenic strain, co-
identical with SAG 10.89 [21]). Both of these latter strains are
placed between the two sub-clades that include the hierridin B
producers. By contrast, Synechococcus sp. WH5701 and Cyanobium
sp. 7001 (which belongs to the same clade as Cyanobium sp. LEGE
06113), and Leptolyngbya sp. PCC 7375 (closely related to P. ectocarpi
SAG 60.90) do possess PKS clusters. Hence, as hypothesized for
other secondary metabolites produced by cyanobacteria
[22,23,24], horizontal transfer of the entire gene cluster may be
responsible for the presence of the hierridin biosynthetic machin-
ery in these two distinct phylotypes. It will thus be of considerable
interest, in particular from the perspective of secondary metabolite
evolution, to study the distribution of hierridin B among
cyanobacteria. However, to achieve this it will be necessary to
identify the cluster of genes involved in its biosynthesis.
Biological activity
Papendorf et al. [9] isolated compound 1 guided by its
antiplasmodial activity (low micromolar IC50). In the same study,
the compound was tested but did not show antibacterial or anti-
algal activity. It was also shown that 1 had no significant inhibitory
activity in in vitro bioassays using HIV-1-reverse transcriptase or
tyrosine kinase [9]. Antiplasmodial activity has been reported for
the related metabolites 3 [25] and miconidin [26]. In this work,
compound 1 showed selective activity, although of modest
potency, towards the HT-29 cell line. The basis for this selectivity
is, at the moment, unclear, but may indicate the existence of a
unique target in this cell line and the possibility of a favorable
therapeutic window. Still, the related benzoquinone irisquinone
[18] did not reveal any such selectivity in the NCI-60 cancer cell
line screening program (NSC Number 614642), in which it
showed an average potency in the low-to-mid micromolar range.
Other benzoquinones, such as 3 and its longer-chain analogue, 2-
methoxy-6-heptyl-1,4-benzoquinone, have been associated with
anticancer activity [27]. To our knowledge, no putative natural
roles have been put forward for 1. It has been found, however, that
naturally occurring concentrations of miconidin and 3 are able to
effectively deter feeding by insects [28]. Cyanobacteria serve as
prey for several insect larvae, and members of the cyanobacterial
genera Fischerella and Hapalosiphon have been reported to produce
insecticidal metabolites [29]. However, the active components of
these latter cyanobacteria bear no structural relatedness to 1.
In conclusion, we report here the isolation and cytotoxicity of a
bioactive secondary metabolite, hierridin B (1), from a marine
picocyanobacterium, Cyanobium sp. LEGE 06113. Interestingly,
this compound had been previously isolated from a phylogenet-
ically distant filamentous cyanobacterium. Future efforts to
elucidate the biosynthetic route to 1 will be of importance not
only in the study of the evolution and distribution of this and other
Figure 5. Selected natural products with structures related to
that of compound 1. Miconidin methyl ether (2), primin (3), 2-
methoxy-6-pentadecyl-1,4-benzoquinone (4), belamcandol A (5) and
the resorcinol monomer of cylindrocyclophane F (6) are shown.
doi:10.1371/journal.pone.0069562.g005
Table 1. Cytotoxicity of 1 towards a panel of human cell
lines. (+ growth inhibition observed, 2 no growth inhibition
observed).
Cell line Type Growth inhibition (IC50)
HepG2 hepatocellular carcinoma 2 (n/a)
HT-29 colon adenocarcinoma + (100.2 mM)
MG63 osteosarcoma 2 (n/a)
PNT2 normal prostate epithelium 2 (n/a)
RKO colon adenocarcinoma 2 (n/a)
SHSY5Y neuroblastoma 2 (n/a)
SKBR3 breast adenocarcinoma 2 (n/a)
T47D breast ductal carcinoma 2 (n/a)
doi:10.1371/journal.pone.0069562.t001
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related natural products, but also to better understand the
pathway cyanobacteria use to create these structures and to which
end they are produced (i.e. from the eco-physiological point of
view). Because Cyanobium spp. in general, and the strain used here
in particular, exhibit high growth rates in laboratory cultures, and
are thus being considered for biotechnological applications (e.g.
[30,31]), metabolite 1 can be considered as an easily accessible by-
product from Cyanobium sp. LEGE 06113 biomass that may add to
the value of its large scale culture.
Materials and Methods
Cyanobacterial strains
Cyanobium sp. LEGE 06113 was isolated from a sand sample in a
Sabellaria sp. reef collected in the lower tide zone of an intertidal
rocky shore (Aguda beach, Portugal, N 41u 029 58,350, W 8u 399
19,220). Field sampling at this location does not require, according
to Portuguese law, any specific permission. In addition, the
sampling did not involve any endangered or protected species. A
monocyanobacterial culture of this strain is maintained in our
culture collection (LEGE). For biomass production and subsequent
chemical investigations, Cyanobium sp. LEGE 06113 cells were
grown in 4 L cultures in Z8 medium [32] supplemented with
20 g L21 NaCl, under a light/dark cycle of 14:10 h and a photon
irradiance of approximately 30 mmol m22 s21. Cells were har-
vested by centrifugation from nine of such cultures, rinsed with
deionized water and freeze-dried. Phormidium ectocarpi SAG 60.90
was acquired from the Culture Collection of Algae at Goettingen
University (SAG) and cultured in MN medium [33], under the
light and temperature conditions described above. Microphoto-
graphs and morphometric measures of cultures of the two
cyanobacterial strains were acquired in a BX41 light microscope
equipped with a DP72 digital camera and Cell B image analysis
software (Olympus, Tokyo, Japan).
DNA extraction, amplification, sequencing and
phylogenetic analysis
Biomass from exponential-phase, small-scale cultures of the two
studied strains, Cyanobium sp. LEGE 06113 and P. ectocarpi SAG
60.90 was harvested (2 mL) by centrifugation. Total genomic
DNA (gDNA) was extracted from the resulting biomass pellets
using a commercial kit (PureLinkTM Genomic DNA Mini Kit,
Invitrogen, Carlsbad, CA, USA) and according to the manufac-
turer’s instructions. A portion of the 16S rRNA gene was amplified
by PCR with primers CYA 359F [34] and 1494Rc [35]. The
primer pair 27F [35] and 781R [34] was used to amplify a
different portion of the same gene in P. ectocarpi SAG 60.90, while
we were unable to obtain this amplicon from Cyanobium sp. LEGE
06113. To amplify polyketide synthase (PKS) genes, primers DKF
and DKR [14], which target the ketosynthase (KS) domain, were
used. The amplified fragments were purified from the excised
agarose gel slices (Cut&Spin columns, GRiSP, Porto, Portugal),
cloned (pGEM-TH Easy vector, Promega, Madison, WI, USA),
and transformed into OneShotH TOP10 cells (Invitrogen).
Following purification (GenEluteTM Plasmid Miniprep Kit,
Sigma-Aldrich, St. Louis, MO, USA), plasmid DNA was
sequenced (Macrogen, Inc., Seoul, Korea) using M13 primers.
The resulting sequences were inspected for quality and deposited
in GenBank (16S rRNA gene – accession numbers KC469577 and
KC469578; PKS genes – accession numbers KF010866 to
KF010868).
A 16S rRNA gene-based phylogenetic tree was constructed to
infer the evolutionary relationship between the two hierridin B
producing strains. Several available cyanobacterial sequences from
unicellular and filamentous non-heterocystous ‘‘Bergey’s reference
strains’’ [11] were included in the analysis. Sequences from the
best BLASTn hits in GenBank for Phormidium ectocarpi SAG 60.90
were also included in the multiple sequence alignment, which was
performed in MEGA version 5 software package [36] using the
ClustalW algorithm. The jModelTest 2.1.1 program [37] was used
to evaluate which model of evolution best-fits our dataset. The
corrected Akaike information criterion (AICc) was used to choose
the optimal model of nucleotide substitution, which allowed us to
select the GTR+C+I model (gamma shape parameter = 0.3860;
number of gamma categories = 4; proportion of invariant
sites = 0.3470). MrBayes version 3.1.2 [38] was then used for
Bayesian inference (BI), using the same model and computing the
parameter values indicated above. The phylogenetic tree recon-
struction was performed using a random starting tree, while one
cold and seven incrementally heated chains (temperature set 0.2)
were run for 107 generations, in two independent runs, with a tree
sampling frequency of 100. The resulting consensus phylogeny was
built from the last 75% of trees. MEGA 5 was also used to build a
maximum-likelihood (ML) bootstrap tree (1000 replicates). The
tree was reconstructed by using the same sequence alignment,
model of evolution and parameters as the used for the Bayesian
inferred tree. Gaps and ambiguously aligned positions were
excluded (‘complete deletion’ option) from the analyses. The
topologies retrieved from the two analyses were then evaluated
using TreePuzzle 5.2 [39]. All the test comparisons indicated that
the ML tree yielded the best topology for the dataset. The branch
support values derived from the ML and BI analyses were then
compared using TreeGraph 2 [40].
The PKS gene sequences obtained from both cyanobacterial
strains were translated and submitted to the software tool NaPDoS
(Natural Product Domain Seeker) [15], to identify the KS
domains. The default parameters for KS domains were used in
the analyses.
Purification and dereplication of 1
Freeze-dried biomass from Cyanobium sp. LEGE 06113 (,10 g,
d.w.) was repeatedly extracted with a warm (,40uC) mixture of
CH2Cl2:MeOH (2:1). The resulting crude extract (,2.7 g) was
subjected to normal-phase (silica gel 60, 0.015–0.040 mm, Merck
KGaA, Damstadt, Germany) VLC, using a gradient from 100%
hexane to 100% EtOAc to 100% MeOH. Nine fractions (A-I)
were obtained and inspected by 1H NMR (500 MHz, Varian
Inova). Fraction B (18.5 mg), putatively containing aromatic
methoxy groups, was selected for further purification by semi-
preparative RP-HPLC. The chromatographic system consisted of
two 515 pumps and a 996 PDA detector (Waters, Milford, MA,
USA), fitted with a Synergi Fusion-RP column (10 mm,
250610 mm, Phenomenex, Torrance, CA, USA). A gradient
program (flow of 3 mL min21) was used for the separation, from
85% MeCN (aq) to 100% MeCN for 30 min, then 100% MeCN
for 13 min, to afford metabolite 1 (0.6 mg, pale yellow amorphous
solid, RT=24.8 min). The 1H NMR (500 MHz, CDCl3) spec-
trum of 1 is available in Fig. S1.
Dereplication of known marine secondary metabolites was
carried out with MarinLit (February 2011 update), by querying for
the two methoxy groups and for a 1,2,3,5-tetrasubstituted
aromatic moiety that was deduced from the meta-coupling
(J=2.8 Hz) of the two aromatic protons.
GC-MS analysis
A TRACE GC Ultra (Thermo Fisher Scientific, Austin, TX,
USA) gas chromatograph coupled with a Polaris Q ion trap mass
spectrometer was used in the analysis. The system included
Antitumor Activity of Hierridin B
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an AS-3000 autosampler. A ZB-XLB capillary column
(30 m60.25 mm60.25 mm) from PhenomenexH (Torrance, CA,
USA) was selected for chromatographic separation. Ultra-pure
grade Helium (Linde So´gas, Lisbon, Portugal; purity $99.999%)
was used as a carrier gas (flow 1.0 mL min21). The system was
controlled by Xcalibur software, Version 1.3 (Thermo Fisher
Scientific). Injections (2 mL) of 1 at a concentration of 2 mg L21
were carried out in the splitless mode and injector temperature was
250uC. The compound was detected by mass spectrometry using
full scan mode (m/z 80-500).
The column oven temperature was programmed as follows:
initial temperature of 150uC and increased by 6uC min21 to
295uC (held for 4 min). The mass spectrometer was operated in
electron ionization (EI) mode at 70 eV with an external ionization
source. A temperature of 285uC was used for the ion source and
the electron multiplier was set at 1750 V (autotune to gain of
16107).
Cell lines and cytotoxicity assays
All cell lines included in the study are of human origin.
Hepatocellular carcinoma cell line HepG2, colon adenocarcinoma
cell line HT-29, neuroblastoma cell line SH-SY5Y, breast
carcinoma cell line T47D and the normal prostate cell line
PNT2 were purchased from Sigma-Aldrich. SKBR3 breast
adenocarcinoma and RKO colon carcinoma (ATCC) were a
kind gift from Helena Fernandes (Faculdade de Medicina
Denta´ria, University of Porto) and MG-63 osteosarcoma was
obtained from the ATCC. Tumor cells were cultured in
Dulbecco’s modified Eagle medium (DMEM Glutamax) and the
normal prostate cell line was cultured in minimal essential medium
(a-MEM), supplemented with 10% fetal bovine serum (FBS),
2.5 mg mL21 fungizone, penicillin-streptomycin (100 IU mL21
and 100 mg mL21, respectively). Cells were incubated in a
humidified atmosphere with 5% of CO2, at 37uC.
The cellular viability was evaluated by the reduction of the 3-
(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) [41]. Cells were seeded in 96-well culture plates at a
concentration of 104 cells cm22. After 24 h of adhesion, cells were
exposed to 100 mL fresh medium supplemented with 1 to a final
concentration of 3 and 30 mg mL21, for a period of either 24, 48
and 72 hours. After incubation, cells were exposed to 10 mL of
0.5 mg/ml MTT. Following exposure, purple-colored formazan
salts were dissolved in 100 ml DMSO and the absorbance
measured at 550 nm in a microplate reader (Synergy HT, Biotek,
USA). All tests were run in triplicate and averaged. A similar
procedure was undertaken for determining the IC50 value of 1 in
the cell line HT-29. In this case, however, cells were incubated for
48 h and the final concentrations of 1 in the culture medium
ranged from 0.03 to 100 mg mL21. Dose-response data was used
to calculate the IC50 with the software GraphPad Prism v5.0
(GraphPad Software, La Jolla, CA, USA).
Supporting Information
Figure S1 1H NMR spectrum (500 MHz, CDCl3) of
hierridin B (1). Insert shows comparison with previously
reported 1H NMR data (300 MHz, CDCl3) for the compound
(Papendorf et al., 1998, Phytochemistry 49:2383–2386).
(TIF)
Figure S2 Cytotoxicity dose-response curve of HT-29
cells exposed to hierridin B (1) (IC50 = 100.2 mM).
(TIF)
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